Show
Sort by
-
Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infection
-
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers
-
Improvement in liver histology after 3 years of E1 therapeutic vaccination in 23 patients with chronic hepatitis C
-
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C
-
HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells
-
Humoral and cellular immune responses to subepidermal E1-based therapeutic vaccination in healthy volunteers and patients with past or ongoing HCV infections
-
Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
-
A candidate therapeutic vaccine for chronic hepatitis C infection based on envelope 1 protein: Tolerability and immunogenicity in healthy adult volunteers
-
Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers.
-
Prevalence of GBV-C/HGV and HCV in 4 hemodialysis units in Flanders (Belgium)